Franziska R.
- Country
- Germany
- Department
- Dermatology
Research Overview
- A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study)
- Efficacy and Safety Evaluation of SAR444656 in Adults with Moderate to Severe Atopic Dermatitis: A Multinational, Double-Blind, Placebo-Controlled Phase 2 Study
- Efficacy and Safety Evaluation of Vilobelimab in Ulcerative Pyoderma Gangrenosum: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial
Data & Insights
Has run more than one trial at 35 of 180 partner sites.
Specializations
Inflammatory Skin Conditions
This investigator specializes in treating severe plaque psoriasis and various forms of psoriatic disease, including generalized pustular psoriasis. Their research extends to both mild-to-moderate and severe manifestations of these conditions.
- Plaque Psoriasis Management
- Pustular Psoriasis Treatment
- Novel Psoriasis Therapies
Chronic Skin Disorders
The investigator focuses on complex dermatological conditions including atopic dermatitis, hidradenitis suppurativa, and prurigo nodularis. Their work encompasses both moderate and severe cases requiring specialized therapeutic approaches.
- Atopic Dermatitis Treatment
- Hidradenitis Suppurativa Management
- Chronic Skin Disease Therapy
Rare Dermatological Conditions
Expertise extends to rare skin disorders including Netherton syndrome, pyoderma gangrenosum, and systemic mastocytosis. The investigator works with novel therapeutic approaches for these challenging conditions.
- Rare Disease Management
- Complex Case Treatment
- Chronic Urticaria Care
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.